Tue. 2 Apr 2024, 7:59am ET
Benzinga
Earnings, News
bioAffinity Technologies (NASDAQ:BIAF) reported quarterly losses of $(0.26) per share. This is a 40.91 percent increase over losses of $(0.44) per share from the same period last year. The company reported $2.21 million in sales this quarter. This is a 5.67 percent decrease over sales of $2.35 million the same period last year.